Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
93.00
-0.52 (-0.56%)
At close: Mar 9, 2026, 4:00 PM EDT
93.22
+0.22 (0.23%)
After-hours: Mar 9, 2026, 6:08 PM EDT

Rhythm Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
6,3517,1433,4402,7171,641502
Upgrade
Market Cap Growth
78.96%107.64%26.64%65.56%227.08%-61.83%
Upgrade
Enterprise Value
6,0746,9873,3972,4191,295176
Upgrade
Last Close Price
93.00107.0455.9845.9729.129.98
Upgrade
PS Ratio
33.4737.6526.4435.0969.42159.06
Upgrade
PB Ratio
44.9426.4620.9116.006.211.77
Upgrade
P/TBV Ratio
47.4853.41221.1716.696.401.80
Upgrade
EV/Sales Ratio
32.0136.8226.1031.2454.7955.81
Upgrade
Debt / Equity Ratio
0.420.420.690.630.290.01
Upgrade
Net Debt / Equity Ratio
-1.02-1.02-1.26-0.99-0.97-1.03
Upgrade
Net Debt / EBITDA Ratio
1.451.451.210.921.441.73
Upgrade
Net Debt / FCF Ratio
2.372.371.821.241.472.00
Upgrade
Asset Turnover
0.440.440.360.220.070.01
Upgrade
Inventory Turnover
0.880.880.981.611.41-
Upgrade
Quick Ratio
3.923.922.945.278.536.81
Upgrade
Current Ratio
4.414.413.245.588.907.10
Upgrade
Return on Equity (ROE)
-90.45%-90.45%-155.91%-85.10%-66.05%-30.89%
Upgrade
Return on Assets (ROA)
-27.51%-27.51%-29.84%-32.22%-31.45%-41.15%
Upgrade
Return on Capital Employed (ROCE)
-51.30%-51.30%-62.50%-66.40%-52.30%-59.40%
Upgrade
Earnings Yield
-3.18%-2.75%-7.58%-6.80%-11.04%-13.88%
Upgrade
FCF Yield
-1.84%-1.63%-3.31%-5.01%-10.59%-29.19%
Upgrade
Buyback Yield / Dilution
-6.54%-6.54%-5.76%-10.65%-5.08%-12.40%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.